Open Access
Subscription Access
Open Access
Subscription Access
Formulation and Evaluation of Transdermal Patches of Selegiline
Subscribe/Renew Journal
Selegiline is an antiparkinsonian drug. It is a MAO-B enzyme inhibitor. It undergoes hepatic first pass metabolism and it result in 10% bioavailability on oral administration. So it was designed to formulate transdermal patches of Selegiline HCl for enhancing the bioavailability and patient compliance. Different formulation were prepared by different grades and varying concentration of polymer by solvent casting method. PG was used as permeation enhancer. The films were subjected to evaluation parameters like weight variation, thickness, moisture content, tensile strength, folding endurance, drug content and in-vitro drug release.
Keywords
Selegiline HCl, Transdermal Patches, Parkinson’s Disease, Drug Content, In-vitro Release
Subscription
Login to verify subscription
User
Font Size
Information
- Prabhakar D, Sreekanth J, Jayaveera KN. Transdermal drug delivery patches: a review. J Drug Deliv Ther. 2013;3(4):213–21.
- Jalwal P, Jangra A, Dhaiya L, Sangwan Y, Saroha R. A review on transdermal patches. Pharm Res. J. 2010; 3:139-149.
- Yadav V. Transdermal drug delivery system: review. Int. J Pharm Sci. Res. 2012;3(2):376-382.
- Dhiman S, Thakur GS, Rehni AK. Transdermal patches: a recent approach to new drug delivery system. Int. J Pharmacy Pharm Sci. 2011;3(5):26-34.
- Sharma RK, Keleb E, Mosa EB, Aljahwi AAZ. Transdermal drug delivery system- design and evaluation. Int. J Advances Pharm Sci. 2010; 1: 201-211.
- Sandhu P, Bilandi A, Kataria S, Middha A. Transdermal drug delivery system (patches), applications in present scenario. Int. J Res. Pharm Chem. 2011;1(4):1139-1151.
- Patel D, Chaudhary SA, Parmar B, Bhura N. Transdermal drug delivery system: a review. The Pharm Innovation. 2012;1(4):66-75.
- “Selegiline from wikipedia, the free encyclopedia,” http:// en.wikipedia.org/wiki/Selegiline.
- K. C. Garala, A. J. Shinde, and P. H. Shah, “Formulation and in-vitro characterization of monolithic matrix transdermal systems using HPMC/Eudragit S 100 polymer blends,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 1, no. 1, pp. 108–120, 2009.
- A. Shivaraj, R. Panner Selvam, T. Tamiz Mani, and T. Sivakumar, “Design and evaluation of transdermal drug delivery of ketotifen fumarate,” International Journal of Pharmaceutical and Biomedical Research, vol. 1, no. 2, pp. 42–47, 2010.
- E. Keleb, R. Sharma, E. B. Mosa, and A. Z. Zaljahwi, “Transdermal drug delivery system- design and evaluation,” International Journal of Advances in Pharmaceutical Sciences, vol. 1, pp. 201–211, 2010.
- S. T. Lec, S. H. Yac, S. W. Kim, and B. Berner, “One-way membrane for transdermal drug delivery system. II. System optimization,” International Journal of Pharmaceutics, vol. 77, no. 2-3, pp. 231–237, 1991.
- Gupta JRD, Tripathi P, Irchhiaya R, Garud N, Dubey P, Patel JR. Skin permeation advancements. Int J Pharm Sci Drug Res. 2009; 1: 146–150.
- Mohammed Gulzar Ahmed, Kiran Kumar GB and Satish Kumar BP. Formulation and Evaluation of Nifedipine Transdermal Patches. J. of Pharm. Research., 3(8), 2010, 1785-1787.
Abstract Views: 98
PDF Views: 0